BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28264911)

  • 1. Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells.
    Liao CP; Chen LY; Luethy A; Kim Y; Kani K; MacLeod AR; Gross ME
    Endocr Relat Cancer; 2017 Apr; 24(4):157-170. PubMed ID: 28264911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.
    Cioni B; Nevedomskaya E; Melis MHM; van Burgsteden J; Stelloo S; Hodel E; Spinozzi D; de Jong J; van der Poel H; de Boer JP; Wessels LFA; Zwart W; Bergman AM
    Mol Oncol; 2018 Aug; 12(8):1308-1323. PubMed ID: 29808619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion.
    Yu S; Xia S; Yang D; Wang K; Yeh S; Gao Z; Chang C
    Med Oncol; 2013; 30(3):674. PubMed ID: 23925662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LMO2 upregulation due to AR deactivation in cancer-associated fibroblasts induces non-cell-autonomous growth of prostate cancer after androgen deprivation.
    Chen L; Wang YY; Li D; Wang C; Wang SY; Shao SH; Zhu ZY; Zhao J; Zhang Y; Ruan Y; Han BM; Xia SJ; Jiang CY; Zhao FJ
    Cancer Lett; 2021 Apr; 503():138-150. PubMed ID: 33503448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal factors involved in human prostate cancer development, progression and castration resistance.
    Eiro N; Fernandez-Gomez J; Sacristán R; Fernandez-Garcia B; Lobo B; Gonzalez-Suarez J; Quintas A; Escaf S; Vizoso FJ
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):351-359. PubMed ID: 27787597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.
    Neuwirt H; Bouchal J; Kharaishvili G; Ploner C; Jöhrer K; Pitterl F; Weber A; Klocker H; Eder IE
    Cell Commun Signal; 2020 Jan; 18(1):11. PubMed ID: 31980029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation.
    Ishii K; Sasaki T; Iguchi K; Kajiwara S; Kato M; Kanda H; Hirokawa Y; Arima K; Mizokami A; Sugimura Y
    Prostate; 2018 Aug; 78(11):849-856. PubMed ID: 29707793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
    Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
    Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.
    Leach DA; Trotta AP; Need EF; Risbridger GP; Taylor RA; Buchanan G
    Prostate; 2017 Feb; 77(2):185-195. PubMed ID: 27718274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation.
    Clocchiatti A; Ghosh S; Procopio MG; Mazzeo L; Bordignon P; Ostano P; Goruppi S; Bottoni G; Katarkar A; Levesque M; Kölblinger P; Dummer R; Neel V; Özdemir BC; Dotto GP
    J Clin Invest; 2018 Dec; 128(12):5531-5548. PubMed ID: 30395538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide analysis of AR binding and comparison with transcript expression in primary human fetal prostate fibroblasts and cancer associated fibroblasts.
    Nash C; Boufaied N; Mills IG; Franco OE; Hayward SW; Thomson AA
    Mol Cell Endocrinol; 2018 Aug; 471():1-14. PubMed ID: 28483704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture.
    Eder T; Weber A; Neuwirt H; Grünbacher G; Ploner C; Klocker H; Sampson N; Eder IE
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor moonlighting in the prostate cancer microenvironment.
    Cioni B; Zwart W; Bergman AM
    Endocr Relat Cancer; 2018 Jun; 25(6):R331-R349. PubMed ID: 29618577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
    Cano P; Godoy A; Escamilla R; Dhir R; Onate SA
    Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.
    Olsen JR; Azeem W; Hellem MR; Marvyin K; Hua Y; Qu Y; Li L; Lin B; Ke X; Øyan AM; Kalland K
    BMC Cancer; 2016 Jul; 16():377. PubMed ID: 27378372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen Signaling in the Tumor Microenvironment.
    Özdemir BC
    Adv Exp Med Biol; 2021; 1270():169-183. PubMed ID: 33123999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.
    Kikuchi K; McNamara KM; Miki Y; Moon JY; Choi MH; Omata F; Sakurai M; Onodera Y; Rai Y; Ohi Y; Sagara Y; Miyashita M; Ishida T; Ohuchi N; Sasano H
    Breast Cancer Res Treat; 2017 Dec; 166(3):709-723. PubMed ID: 28831645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells.
    Basrawala Z; Alimirah F; Xin H; Mohideen N; Campbell SC; Flanigan RC; Choubey D
    Oncogene; 2006 May; 25(19):2812-7. PubMed ID: 16331249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Jackson KM; Frazier MC; Harris WB
    Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.